India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to transform access to weight-loss treatment.
What began as a local tragedy spiralled into a national debate about Korean content, its growing popularity among young people in India, and whether it had pushed the sisters over the edge.
By next weekend, Bangladesh will have an elected government. This is India’s moment to reboot broken ties by moderating the ‘ghuspethiya’ rhetoric in poll-bound West Bengal and Assam.
COMMENTS